Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional

AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both

ClinicalTrials.gov ID: NCT07931573

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07931573. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 11:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Zenagamtide s.c. Once Weekly Compared to Semaglutide s.c. Once Weekly at Higher Dose Levels in Participants With Type 2 Diabetes Inadequately Controlled on Metformin, SGLT2i, or Both (AMBITION 3)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have type 2 diabetes. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will get one of the following: Zenagamtide (the treatment being tested) or Semaglutide (an approved and commonly prescribed treatment used as comparator).

Study identification

NCT ID
NCT07931573
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,200 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 10, 2026 (Estimated)
Primary completion
Jul 4, 2028 (Estimated)
Completion
Aug 8, 2028 (Estimated)
Last update posted
Nov 12, 2026

2026 – 2028

United States locations

U.S. sites
55
U.S. states
22
U.S. cities
51
Facility City State ZIP Site status
Rio Clinical Trials Arizona Phoenix Arizona 85016 —
Scripps Whittier Diabetes Inst La Jolla California 92037 —
Diabetes & Endocrine Specialists - La Mesa La Mesa California 91942 —
First Valley Med Grp Lancaster Lancaster California 93534 —
Los Angeles Institute for Metabolic Research Los Angeles California 90015 —
Valley Clinical Trials, Inc. Northridge California 91325 —
Desert Oasis Hlthcr Med Group Palm Springs California 92262 —
Linda Vista Health Care Ctr San Diego California 92111 —
Southern Cal Clinical Research Santa Ana California 92701 —
Encompass Clinical Research_Spring Valley Spring Valley California 91978 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Chase Medical Research LLC Waterbury Connecticut 06708 —
Encore Medical Research LLC Hollywood Florida 33024 —
University of Florida Cardiology Jacksonville Florida 32256 —
My Preferred Research Miami Florida 33155 —
New Horizon Research Center Miami Florida 33165 —
GTL Med & Res Group Miami Florida 33173 —
Life Medical Research Group Miami Gardens Florida 33014 —
South Broward Research LLC Miramar Florida 33027 —
Adult Medicine of Lake County, Inc Mt. Dora Florida 32757 —
West Orange Endocrinology Ocoee Florida 34761 —
Florida Institute for Clinical research Orlando Florida 32825 —
True Blue Clinical Research Tampa Florida 36607 —
Encore Medical Research of Weston Weston Florida 33331 —
Solaris Clinical Research Meridian Idaho 83646 —
Clinical Invest Special_Gurnee Gurnee Illinois 60031 —
Cotton O'Neil Diab & Endo Ctr Topeka Kansas 66606 —
MedStar Health Research Institute Olney Maryland 20832 —
Endo And Metab Cons Rockville Maryland 20852 —
Brigham & Women's Hospital Boston Massachusetts 02115 —
Elite Clinical Research Flint Michigan 48532 —
StudyMetrix Research LLC City of Saint Peters Missouri 63303 —
Palm Research Center Inc-Vegas Las Vegas Nevada 89148 —
Southern NH Diabetes and Endo_Nashua Nashua New Hampshire 03060 —
AMC Community Endocrinology Albany New York 12203 —
Southgate Medical Group, LLP West Seneca New York 14224 —
PharmQuest Life Sciences LLC Greensboro North Carolina 27408 —
Monroe Biomedical Research, LLC Monroe North Carolina 28112 —
Accellacare Wilmington North Carolina 28401 —
Diab & Endo Assoc of Stark Co Canton Ohio 44718 —
DelRicht Research at Newton Family Medicine Charleston South Carolina 29407 —
Spartanburg Medical Research Spartanburg South Carolina 29303 —
South Dakota Urban Indian Health Sioux Falls South Dakota 57104 —
Holston Medical Group Pc Bristol Tennessee 37620-7352 —
Holston Medical Group Kingsport Tennessee 37660 —
Clinical Research Associates Nashville Tennessee 37203 —
Victorium Clinical Research Houston Texas 77024 —
Southwest Clinical Trials Houston Texas 77074 —
Medical Colleagues-Texas LLP Katy Texas 77450 —
Pinnacle Clinical Research San Antonio Texas 78222 —
NE Clin Res of San Antonio San Antonio Texas 78233 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —
Texas Valley Clinical Research Weslaco Texas 78596 —
Diabetes & Endo Treatment Spec Sandy City Utah 84093 —
Rainier Clin Res Ctr Inc Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 175 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07931573, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 12, 2026 · Synced Nov 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.